Deepika Gulati is a Singapore citizen, technology and business leader who founded Solivia Pte. Ltd. to make a profound impact globally. Meaning "the path lit by sunlight," Solivia was built with a clear mission: to make certified, safe and high-quality medical products accessible across advanced, emerging and underserved healthcare markets worldwide.
Deepika holds a Master's degree in Psychology and began her professional journey as an intern with the American Red Cross in Delhi, working directly with underprivileged communities. This early experience deeply shaped her belief in service, dignity and social impact, strengthening a lifelong commitment to improving access to care for those who need it most.
Her unique perspective on global clinical supply chains draws from years of experience with medical industry leaders including Abbott and ResMed. This expertise is further backed by her family's 30-plus-year legacy in medical device manufacturing in India, giving her exceptional exposure to quality, rigorous compliance, absolute reliability and the patient-focused mindset that global healthcare demands.
Through Solivia, Deepika brings together her background in psychology, healthcare, technology, manufacturing and community service to build a trusted global clinical distribution platform that empowers hospitals, clinics, distributors, governments and care providers worldwide.
Platform-wide manufacturing certifications.
Every product distributed through the Solivia platform is manufactured in facilities holding the most rigorous international quality, sterility and compliance certifications.
ISO 13485:2016
Full QMS certification for medical device manufacturing, audited, consistent standards across production, packaging, sterilization and distribution.
EN 13795 & AAMI
European and American standards validating fluid resistance, cleanliness and barrier effectiveness of all surgical textile products distributed by Solivia.
WHO GMP
World Health Organization Good Manufacturing Practice, ensuring all manufacturing facilities, processes and personnel meet global healthcare production benchmarks.
CE (EU MDR 2017/745)
CE marking under the European Medical Device Regulation, the most rigorous global standard for medical device compliance and patient safety validation.
ZED Gold · IS-17334
ZED Gold (Zero Defect Zero Effect) and IS-17334 Bureau of Indian Standards certification, reflecting India's highest manufacturing quality and regulatory recognition.
SFDA · Star Export House
Saudi Food & Drug Authority approval and Government of India Star Export House recognition, affirming global-standard production excellence and trusted international trade status.
Certificate thumbnails shown for illustration. Sensitive details redacted; full documents available on request to verified partners.
Why partner with the Solivia clinical distribution platform?
We bring together certified manufacturing, two complementary clinical product lines, a global distribution vision and Singapore-based operational excellence, built for the healthcare institutions, distributors and governments of tomorrow.
Truly global clinical distribution
Unlike regional suppliers, Solivia is built as a global clinical distribution platform, supplying certified healthcare products to hospitals, distributors, governments and care providers across advanced, emerging and underserved markets worldwide.
Two product lines, one platform
Solivia is the only global platform distributing both certified surgical PPE and validated infection control medical devices, eliminating supplier fragmentation and giving healthcare institutions a single trusted source for complete clinical safety.
World-class certified manufacturing
All products come from ISO 13485, CE (EU MDR 2017/745), WHO GMP, EN 13795 and ZED Gold certified manufacturing facilities, with 100K and 10K clean-room production, in-house sterilization and testing labs.
Platform built for scale
Solivia's distribution model is designed for rapid international scale, with digital procurement infrastructure, regional distribution partnerships and an expanding product portfolio moving into consumer healthcare and emerging markets.